Actively Recruiting

Phase Not Applicable
Age: 18Years - 70Years
All Genders
ID06369532

Stop Worrying, Learn to Let Go Through a Combination of Neurostimulation and Psychotherapy

Led by University Hospital, Ghent · Updated on 2026-03-12

85

Participants Needed

1

Research Sites

12 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Researchers are investigating whether combining transcranial Direct Current Stimulation (tDCS) with cognitive-behavioral therapy (CBT) improves treatment for repetitive negative thinking (RNT) in patients who experience high levels of rumination. This study includes patients with generalized anxiety disorder or depressive disorder and compares active tDCS combined with CBT to sham (inactive) tDCS combined with CBT to evaluate their therapeutic effects. The study has two stages. In the first stage, participants attend weekly CBT group sessions called "Drop It" for 7 weeks, each followed by either active or sham tDCS applied for 30 minutes. In the second stage, after these sessions, participants use the tDCS devices at home daily for 4 weeks, continuing with either active or sham stimulation, then return for a final CBT session. Neuroimaging scans (EEG and fNIRS) are done at the start and after 3 months of therapy to measure brain activity. During the study, participants complete questionnaires assessing worry, depression, anxiety, and quality of life at baseline, after the therapy course, and at 3-month follow-up. Psychiatrists also evaluate participants at these points. Questionnaires measuring rumination are completed after each session. The main outcomes are the therapeutic effect of the combination therapy and the lasting impact of tDCS on CBT benefits, with safety and brain activity monitored over up to 3 months. Participation lasts approximately 3 months.

CONDITIONS

Brief Title

Combination of Neurostimulation and Psychotherapy to Stop Worrying

Who Can Participate

Age: 18Years - 70Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Adults aged 18 to 70 years
  • Diagnosis of generalized anxiety disorder (GAD)
  • Diagnosis of depressive disorder
  • Ability to commit to 8 sessions of cognitive-behavioral therapy (CBT)
  • Ability to receive 4 weeks of transcranial Direct Current Stimulation (tDCS)
  • Sufficient knowledge of Dutch language
Not Eligible

You will not qualify if you...

  • Presence of psychiatric disorders other than GAD or depression as assessed by a senior psychiatrist
  • Abuse of alcohol, drugs, or medications not prescribed by a doctor
  • Lack of consent to participate in measurements such as questionnaires, fNIRS, or EEG
  • Acute or chronic suicidality
  • Acute psychosis or manic depressive disorder
  • Inability to commit to the full therapy and stimulation schedule

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Treatment

Duration - 7 weeks

Participants attend weekly cognitive-behavioral therapy (CBT) sessions for 7 weeks. After each session, they receive either active or sham transcranial Direct Current Stimulation (tDCS) for 30 minutes.

7 weekly visits (in-person)

Treatment

Duration - 4 weeks

Participants apply daily home-based active or sham tDCS for 4 weeks following the initial 7 CBT sessions.

Daily home-based stimulation

Treatment

Duration - 1 day

Participants return to the university hospital for the final CBT session after completing home-based tDCS.

1 visit (in-person)

Follow-up

Duration - 3 months from baseline

Participants complete questionnaires and undergo EEG and fNIRS neuroimaging to evaluate therapeutic effects at 3 months after starting therapy.

1 visit (in-person)

Trial Site Locations

Total: 1 location

1

University Hospital Ghent

Ghent, East-Flanders, Belgium, 9000

Actively Recruiting

Loading map...

Research Team

C

Chris Baeken

S

Sara De Witte

How is the study designed?

Study Type

INTERVENTIONAL

Masking

TRIPLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Published Research Related To This Trial

Cognitive behavioral based group psychotherapy focusing on repetitive negative thinking: Decreased uncontrollability of rumination is related to brain perfusion increases in the left dorsolateral prefrontal cortex.

Chris Baeken, Guo-Rong Wu, Roland Rogiers...

https://pubmed.ncbi.nlm.nih.gov/33621914

Combined transcranial direct current stimulation and psychological interventions: State of the art and promising perspectives for clinical psychology.

Josefien Dedoncker, Chris Baeken, Rudi De Raedt...

https://pubmed.ncbi.nlm.nih.gov/33232800